Safety and clinical activity of atezolizumab plus ipilimumab in locally advanced or metastatic non-small cell lung cancer: results from a phase 1b trial

HIGHLIGHTS

• who: Deborah J. Wong from the David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA , Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN , HonorHealth Research Institute, Scottsdale, AZ , FHoffmann-La Roche Ltd, Mississauga, ON, Canada , Genentech, Inc, South San Francisco, CA Submitted: Mar, have published the research work: Safety and Clinical Activity of Atezolizumab Plus Ipilimumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Results From a Phase 1b Trial, in the Journal: (JOURNAL) of Mar/10,/2021
• what: Twenty-seven patients were enrolled 4 with melanoma and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.